Brief: Kimia Biosciences Gets India Drug Regulator Nod To Manufacture Brivaracetam For Sale Or Distribution
22/02/2021 13:13
Feb 22 (Reuters) - Kimia Biosciences Ltd KIMI.BO :
* KIMIA BIOSCIENCES -GOT PERMISSION TO MANUFACTURE NEW API
FOR
SALE OR DISTRIBUTION OF BRIVARACETAM BY CENTRAL DRUGS STANDARD
CONTROL ORGANIZATION
Source text for Eikon: ID:nBSE1hPdcd
Further company coverage: KIMI.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kimia Biosciences
See all newsBrief: Kimia Biosciences Ltd Says Naveen Sharma Resigns As CFO
Brief: Kimia Biosciences Appoints Naveen Sharma As CFO
Brief: Kimia Biosciences Pradip Kumar Sharma Resigns as Chief Financial Officer
Brief: Kimia Biosciences Says Rakesh Chetani Resigns As CFO
Brief: Kimia Biosciences Gets Order Worth $200,000